Neuralink Demonstrates Thought-to-Speech in ALS Patient Through VOICE Trial
Neuralink demonstrated thought-to-speech technology in ALS patient Kenneth Shock, the second participant in its VOICE clinical trial implanted in January 2026.
Two People Used AI to Treat Cancer When Institutions Couldn't. Both Worked.
A tech CEO used AI to direct his own cancer treatment into remission. A developer used AI to design an mRNA vaccine for his dog's cancer. Both bypassed institutional gatekeeping.
